Microbial, Plant, and Invertebrate Test Methods in Regulatory Soil Ecotoxicology

2020 ◽  
pp. 369-388
Author(s):  
Jörg Römbke ◽  
Fabrice Martin-Laurent
Keyword(s):  
Test Methods ◽  
Soil Ecotoxicology

scholarly journals Terrestrial isopods as model organisms in soil ecotoxicology: a review

ZooKeys ◽  
2018 ◽  
Vol 801 ◽  
pp. 127-162 ◽  
Author(s):  
Cornelis A.M. van Gestel ◽  
Susana Loureiro ◽  
Promoz Zidar
Keyword(s):  
Test Methods ◽  
In Situ Monitoring ◽  
Model Organisms ◽  
Toxicity Tests ◽  
Special Focus ◽  
Toxicity Data ◽  
Soil Ecotoxicology ◽  
Soil Ecosystem Services ◽  
Test Organisms

Isopods play an important role in the decomposition of leaf litter and therefore are making a significant contribution to nutrient cycling and soil ecosystem services. As a consequence, isopods are relevant models in soil ecotoxicology, both in laboratory toxicity tests and in field monitoring and bioindication studies. This paper aims at reviewing the use of isopods as test organisms in soil ecotoxicology. It provides an overview of the use of isopods in laboratory toxicity tests, with special focus on comparing different exposure methods, test durations, and ecotoxicological endpoints. A brief overview of toxicity data suggests that chemicals are more toxic to isopods when exposed through soil compared to food. The potential of isopods to be used in bioindication and biomonitoring is discussed. Based on the overview of toxicity data and test methods, recommendations are given for the use of isopods in standardized laboratory toxicity tests as well as in situ monitoring studies.

Laboratory proficiency in susceptibility testing of Helicobacter pylori using agar dilution and E test methods

2001 ◽  
Vol 120 (5) ◽  
pp. A586-A587
Author(s):  
L BEST ◽  
S JO ◽  
V VANZANTEN ◽  
D HALDANE ◽  
V LOO ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Susceptibility Testing ◽  
Test Methods ◽  
Agar Dilution

Scientific and Standardization Committee Communications Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-I (ISLA-1)

1990 ◽  
Vol 64 (03) ◽  
pp. 478-484 ◽  
Author(s):  
Thomas Exner ◽  
Douglas A Triplett ◽  
David A Taberner ◽  
Margaret A Howard ◽  
E Nigel Harris
Keyword(s):  
Lupus Anticoagulant ◽  
Test Methods ◽  
Positive Sample ◽  
Direct Proportion ◽  
Clotting Time ◽  
Preliminary Screening ◽  
Activated Platelets ◽  
Tissue Thromboplastin ◽  
Kaolin Clotting Time ◽  
Induced Defects

SummarySix lyophilized plasma samples were sent to 20 “expert” laboratories for assessment of lupus anticoagulant (LA). Four samples contained pooled LA of graded potency mixed with aged normal plasma. One contained LA plus cephalin phospholipid and one contained a nonspecific venom anticoagulant. Sixteen methods were used overall with some participants using up to 8 methods. Results were scored in regard to the known potencies of LA in the samples and other known induced defects.Activated partial thromboplastin time (APTT) tests used by most participants for preliminary screening were relatively sensitive, but non-specific. Platelet or phospholipid neutralization procedures (PNP) appeared to be sensitive and specific but showed a non-linear response to increased LA content. Kaolin clotting time (KCT) tests showed the most sensitive response to increased LA content but the weaker LA were not scored as abnormal by most laboratories as the samples may have contained platelet fragments. Other commonly used tests such as the tissue thromboplastin inhibition (TTI) test and the dilute Russell’s viper venom test (DRVVT) were carried out somewhat inconsistently. The variability in performance of tests in different laboratories indicates that standardization of methodology is urgently required.Generally it seemed that most clotting tests were “bypassed” by the addition of phospholipid to a known LA-positive sample in apparently direct proportion to their sensitivity. Sample preparation, especially prevention of contamination with activated platelets is a vital preliminary part in the assay of LA.

A method for measuring the in-plane compressive strength and the compression behavior of coating layers

TAPPI Journal ◽  
2011 ◽  
Vol 10 (7) ◽  
pp. 29-34
Author(s):  
TEEMU PUHAKKA ◽  
ISKO KAJANTO ◽  
NINA PYKÄLÄINEN
Keyword(s):  
Tensile Strength ◽  
Compressive Strength ◽  
Calcium Carbonate ◽  
Coating Layer ◽  
Test Methods ◽  
Coating Films ◽  
Precipitated Calcium Carbonate ◽  
Coating Color ◽  
Mineral Coatings ◽  
Styrene Butadiene

Cracking at the fold is a quality defect sometimes observed in coated paper and board. Although tensile and compressive stresses occur during folding, test methods to measure the compressive strength of a coating have not been available. Our objective was to develop a method to measure the compressive strength of a coating layer and to investigate how different mineral coatings behave under compression. We used the short-span compressive strength test (SCT) to measure the in-plane compressive strength of a free coating layer. Unsupported free coating films were prepared for the measurements. Results indicate that the SCT method was suitable for measuring the in-plane compressive strength of a coating layer. Coating color formulations containing different kaolin and calcium carbonate minerals were used to study the effect of pigment particles’ shape on the compressive and tensile strengths of coatings. Latices having two different glass transition temperatures were used. Results showed that pigment particle shape influenced the strength of a coating layer. Platy clay gave better strength than spherical or needle-shaped carbonate pigments. Compressive and tensile strength decreased as a function of the amount of calcium carbonate in the coating color, particularly with precipitated calcium carbonate. We also assessed the influence of styrene-butadiene binder on the compressive strength of the coating layer, which increased with the binder level. The compressive strength of the coating layer was about three times the tensile strength.

An evaluation of ECT sample height for small flute board grades and Box Manufacturer’s Certification compliance

TAPPI Journal ◽  
2009 ◽  
Vol 8 (6) ◽  
pp. 24-28
Author(s):  
CORY JAY WILSON ◽  
BENJAMIN FRANK
Keyword(s):  
Compressive Strength ◽  
Compressive Load ◽  
Test Sample ◽  
Test Methods ◽  
Test Method ◽  
Initial Development ◽  
Sample Height ◽  
Relationship Of ◽  
The Relationship ◽  
Corrugated Fiberboard

TAPPI test T811 is the specified method to ascertain ECT relative to box manufacturer’s certification compliance of corrugated fiberboard under Rule 41/ Alternate Item 222. T811 test sample heights were derived from typical board constructions at the time of the test method’s initial development. New, smaller flute sizes have since been developed, and the use of lighter weight boards has become more common. The T811 test method includes sample specifications for typical A-flute, B-flute, and C-flute singlewall (and doublewall and triplewall) structures, but not for newer thinner E-flute or F-flute structures. This research explores the relationship of ECT sample height to measured compressive load, in an effort to determine valid E-flute and F-flute ECT sample heights for use with the T811 method. Through this process, it identifies challenges present in our use of current ECT test methods as a measure of intrinsic compressive strength for smaller flute structures. The data does not support the use of TAPPI T 811 for ECT measurement for E and F flute structures, and demonstrates inconsistencies with current height specifi-cations for some lightweight B flute.

340. The Ability of Five Fit-Test Methods to Screen Out Poorly Fitting N95 Fil Teringfacepiece Respirators

2001 ◽  
Author(s):  
R. Lawrence ◽  
C. Coffey ◽  
Z. Zhuang ◽  
D. Campbell
Keyword(s):  
Test Methods

172. Comparison of Three Commercially Available Fit Test Methods

2001 ◽  
Author(s):  
L. Janssen ◽  
M. Luinenburg ◽  
H. Mullins ◽  
T. Nelson
Keyword(s):  
Test Methods

DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION

2020 ◽  
Vol 57 (3) ◽  
pp. 316-322
Author(s):  
Rejane MATTAR ◽  
Sergio Barbosa MARQUES ◽  
Maurício Kazuyoshi MINATA ◽  
Joyce Matie Kinoshita da SILVA-ETTO ◽  
Paulo SAKAI ◽  
...  
Keyword(s):  
Diagnostic Accuracy ◽  
Negative Likelihood Ratio ◽  
Occult Blood ◽  
Test Methods ◽  
Advanced Adenoma ◽  
Sample Collection ◽  
Likelihood Ratios ◽  
Intestinal Neoplasia ◽  
Two Samples ◽  
Eiken Chemical

ABSTRACT BACKGROUND: Rectal bleeding is the most important symptom of intestinal neoplasia; thus, tests of occult blood detection in stools are widely used for pre neoplastic lesions and colorectal cancer (CRC) screening. OBJECTIVE: Evaluate the accuracy of OC-Sensor quantitative test (Eiken Chemical, Tokyo, Japan) at cut-off 10 µg Hb/g feces (50 ng/mL) in a cohort of subjects that had to undergo diagnostic colonoscopy, and if more than one sample collected in consecutive days would improve the diagnostic accuracy of the test. METHODS: Patients (mean age 56.3±9.7 years) that underwent colonoscopy prospectively randomly received one (1-sample FIT, FIT 1) or two (2-sample FIT, FIT 2) collection tubes. They collected the stool sample before starting colonoscopy preparation. Samples were analyzed by the OC-Auto Micro 80 (Eiken Chemical, Tokyo, Japan). The performance of FIT 1 and FIT 2 were compared to the colonoscopy findings. RESULTS: Among 289 patients, CRC was diagnosed in 14 (4.8%), advanced adenoma in 37 (12.8%), early adenoma in 71 (24.6%) and no abnormalities in 141 (48.8%). For FIT 1, the sensitivity for CRC was 83.3% (95%CI 36.5-99.1%), for advanced adenoma was 24% (95%CI 10.1-45.5%), with specificity of 86.9% (95%CI 77.3-92.9%). For FIT 2, the sensitivity for CRC was 75% (95%CI 35.6-95.5%), for advanced adenoma was 50% (95%CI 22.3-77.7%), with specificity of 92.9% (95%CI 82.2-97.7%). The positive likelihood ratios were 1.8 (95%CI 0.7-4.4 for FIT 1) and 7.1 (95%CI 2.4-21.4 for FIT 2) for advanced adenoma, and 6.4 (95%CI 3.3-12.3, for FIT 1) and 10.7 (95%CI 3.8-29.8, for FIT 2) for CRC. The negative likelihood ratio were 0.9 (95%CI 0.7-1, for FIT 1) and 0.5 (95%CI 0.3-0.9, for FIT 2) for advanced adenoma, and 0.2 (0.03-1.1, for FIT 1) and 0.3 (0.08-0.9, for FIT 2) for CRC. The differences between FIT 1 and FIT 2 performances were not significant. However, the comparison of the levels of hemoglobin in feces of patients of FIT 1 and FIT 2 showed that the differences between no polyp group and advanced adenoma and CRC were significant. CONCLUSION: The accuracy of OCR Sensor with 10 µg Hb/g feces cut-off was comparable to other reports and two-sample collection improved the detection rate of advanced adenoma, a pre neoplastic condition to prevent CRC incidence.

Sign in / Sign up

Export Citation Format

Share Document